Oncolix, Inc. Deferred Tax Assets, Valuation Allowance

Oncolix, Inc. Deferred Tax Assets, Valuation Allowance

Oncolix, Inc. had Deferred Tax Assets, Valuation Allowance of -$4.16 million as of 2017-12-31, per its 10-K filed 2018-03-14.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2018-03-14

• 2017-12-31: Deferred Tax Assets, Valuation Allowance -$4.16M.
• 2016-12-31: Deferred Tax Assets, Valuation Allowance -$5.91M; Deferred Tax Assets, Valuation Allowance as first filed $2.02M.
• 2016-09-30: Deferred Tax Assets, Valuation Allowance $232.00K.
• 2016-06-30: Deferred Tax Assets, Valuation Allowance $227.00K.